Search

Your search keyword '"Jauch, Karl-Walter"' showing total 241 results

Search Constraints

Start Over You searched for: Author "Jauch, Karl-Walter" Remove constraint Author: "Jauch, Karl-Walter" Database MEDLINE Remove constraint Database: MEDLINE
241 results on '"Jauch, Karl-Walter"'

Search Results

1. Cold Preservation of Human Hepatocytes with High Viability.

2. Regional hyperthermia with cisplatin added to gemcitabine versus gemcitabine in patients with resected pancreatic ductal adenocarcinoma: The HEAT randomised clinical trial.

3. COVID-19 management at one of the largest hospitals in Germany: Concept, evaluation and adaptation.

4. [Psychosocial support during the COVID-19 pandemic: interdisciplinary concept of care at a university hospital].

5. Role of psychiatric hospitals during a pandemic: introducing the Munich Psychiatric COVID-19 Pandemic Contingency Plan.

6. [Analysis of Treatment Figures in the Munich Emergency Rooms 2013-2014].

7. Concurrent isolation of hepatic stem cells and hepatocytes from the human liver.

8. Tumor biology and multidisciplinary strategies of oligometastasis in gastrointestinal cancers.

10. Tumor-Derived Extracellular Vesicles Inhibit Natural Killer Cell Function in Pancreatic Cancer.

11. Targeting cancer stem cells and their niche: perspectives for future therapeutic targets and strategies.

12. Effect of Neoadjuvant Chemotherapy Plus Regional Hyperthermia on Long-term Outcomes Among Patients With Localized High-Risk Soft Tissue Sarcoma: The EORTC 62961-ESHO 95 Randomized Clinical Trial.

15. Elevated interferon-induced protein with tetratricopeptide repeats 3 (IFIT3) is a poor prognostic marker in pancreatic ductal adenocarcinoma.

16. Targeting Cancer Stem Cells and Their Niche: Current Therapeutic Implications and Challenges in Pancreatic Cancer.

17. Prognosis of mucinous and signet-ring cell colorectal cancer in a population-based cohort.

18. The current status of immunotherapy in peritoneal carcinomatosis.

19. Genetic engineering of mesenchymal stromal cells for cancer therapy: turning partners in crime into Trojan horses.

20. Outcome of gastric cancer in the elderly: a population-based evaluation of the Munich Cancer Registry.

21. Verapamil inhibits tumor progression of chemotherapy-resistant pancreatic cancer side population cells.

22. Results of the TOP Study: Prospectively Randomized Multicenter Trial of an Ex Vivo Tacrolimus Rinse Before Transplantation in EDC Livers.

23. Model for end-stage liver disease score in the first 3 weeks after liver transplantation as a predictor for long-term outcome.

24. Sirolimus Use in Liver Transplant Recipients With Hepatocellular Carcinoma: A Randomized, Multicenter, Open-Label Phase 3 Trial.

25. Antisense inhibition of microRNA-21 and microRNA-221 in tumor-initiating stem-like cells modulates tumorigenesis, metastasis, and chemotherapy resistance in pancreatic cancer.

26. Thirty-day mortality leads to underestimation of postoperative death after liver resection: A novel method to define the acute postoperative period.

27. A-Part Gel, an adhesion prophylaxis for abdominal surgery: a randomized controlled phase I-II safety study [NCT00646412].

28. Impact of the spheroid model complexity on drug response.

29. Histomorphologic and molecular phenotypes predict gemcitabine response and overall survival in adenocarcinoma of the ampulla of Vater.

30. Side population cells of pancreatic cancer show characteristics of cancer stem cells responsible for resistance and metastasis.

31. Overexpression of IFN-induced protein with tetratricopeptide repeats 3 (IFIT3) in pancreatic cancer: cellular "pseudoinflammation" contributing to an aggressive phenotype.

32. Impact of perioperative allogeneic red blood cell transfusion on recurrence and overall survival after resection of colorectal liver metastases.

33. Effectiveness of regional hyperthermia with chemotherapy for high-risk retroperitoneal and abdominal soft-tissue sarcoma after complete surgical resection: a subgroup analysis of a randomized phase-III multicenter study.

34. Loss of liver transplant surgeons into alternate career paths.

35. Augmenter of liver regeneration attenuates inflammatory response in the postischemic mouse liver in vivo.

36. Combination of antiangiogenic therapy using the mTOR-inhibitor everolimus and low-dose chemotherapy for locally advanced and/or metastatic pancreatic cancer: a dose-finding study.

37. Has the minimum caseload requirement failed? Strategic planning in the hospital sector requires input from elected political representatives.

38. Liver resection in the elderly: significance of comorbidities and blood loss.

39. Level of hospital care and outcome of gastric cancer: a population-based evaluation of the Munich Cancer Registry.

40. Long-term oncologic outcome after laparoscopic surgery for rectal cancer.

41. Metabolic self-destruction in critically ill patients: origins, mechanisms and therapeutic principles.

42. Hypoxia-independent gene expression mediated by SOX9 promotes aggressive pancreatic tumor biology.

43. PVA gel as a potential adhesion barrier: a safety study in a large animal model of intestinal surgery.

44. Stem cell-like side populations in esophageal cancer: a source of chemotherapy resistance and metastases.

45. Perfusion characteristics of parotid gland tumors evaluated by contrast-enhanced ultrasound.

46. Impact of cyclosporine versus tacrolimus on the incidence of de novo malignancy following liver transplantation: a single center experience with 609 patients.

47. C-type natriuretic peptide slows down wound healing but promotes angiogenesis in SKH1-hr hairless mice.

48. Surgery for metastasis to the pancreas: is it safe and effective?

49. [Significance of emergency and complication management].

50. Clinical outcome of IBD-associated versus sporadic colorectal cancer: a matched-pair analysis.

Catalog

Books, media, physical & digital resources